Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus-infected Cirrhosis”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Early research (Phase 1)Study completedNCT01289951
What this trial is testing

Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis

Who this might be right for
Human Immunodeficiency VirusHepatitis C
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 10
Testing effectiveness (Phase 2)Study completedNCT01636778
What this trial is testing

Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 45
Large-scale testing (Phase 3)Ended earlyNCT00811967
What this trial is testing

Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED)

Who this might be right for
Hepatitis C, ChronicLiver Cirrhosis
Merck Sharp & Dohme LLC 50
Post-approval studies (Phase 4)Study completedNCT00056862
What this trial is testing

Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3

Who this might be right for
Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 58
Large-scale testing (Phase 3)Study completedNCT02582632
What this trial is testing

Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults

Who this might be right for
Hepatitis C InfectionHepatitis C Virus
AbbVie 166
Not applicableUnknownNCT01268865
What this trial is testing

Acoustic Radiation Force Impulse (ARFI)Technology in Prediction of Liver Fibrosis

Who this might be right for
Liver Fibrosis
China Medical University Hospital 200
Not applicableStudy completedNCT01980290
What this trial is testing

Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis, Chronic
Janssen Pharmaceutica N.V., Belgium 50
Post-approval studies (Phase 4)Study completedNCT02128542
What this trial is testing

Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 66
Not applicableStudy completedNCT02828254
What this trial is testing

A Follow-up Evaluation Study of PRI-724-1101

Who this might be right for
Hepatitis C Virus-infected Cirrhosis
Komagome Hospital 8
Testing effectiveness (Phase 2)Study completedNCT00018031
What this trial is testing

Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients

Who this might be right for
Hepatitis CHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Large-scale testing (Phase 3)Study completedNCT02207088
What this trial is testing

Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease

Who this might be right for
Chronic Hepatitis CHepatitis C VirusCompensated Cirrhosis+2 more
AbbVie 68
Not applicableStudy completedNCT01908660
What this trial is testing

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

Who this might be right for
Human Immunodeficiency VirusHepatitis B, ChronicHepatitis C, Chronic
Valme University Hospital 192
Not applicableStudy completedNCT02060162
What this trial is testing

Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa

Who this might be right for
Hepatitis B VirusHIVAntiretroviral Therapy+3 more
University of Alabama at Birmingham 897
Large-scale testing (Phase 3)Study completedNCT02939989
What this trial is testing

Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study

Who this might be right for
Hepatitis C Virus Infection
AbbVie 33
Large-scale testing (Phase 3)UnknownNCT02961426
What this trial is testing

Strategic Transformation of the Market of HCV Treatments

Who this might be right for
Hepatitis C
Drugs for Neglected Diseases 603
Large-scale testing (Phase 3)Study completedNCT04155515
What this trial is testing

A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I Patients

Who this might be right for
Chronic Hepatics C Virus (HCV) Genotype 1Non-CirrhoticCirrhosis+1 more
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. 370
Large-scale testing (Phase 3)Study completedNCT01704755
What this trial is testing

Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis

Who this might be right for
Chronic Hepatitis C InfectionCompensated Cirrhosis
AbbVie (prior sponsor, Abbott) 381
Large-scale testing (Phase 3)WithdrawnNCT00381017
What this trial is testing

Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)

Who this might be right for
Hepatitis CLiver CirrhosisHIV Infections
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Study completedNCT03593447
What this trial is testing

To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patients

Who this might be right for
Chronic Hepatics C Virus (HCV) Genotype 1Non-CirrhoticCirrhosis+1 more
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. 133
Testing effectiveness (Phase 2)Study completedNCT01687257
What this trial is testing

Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation

Who this might be right for
Hepatitis CCirrhosisPortal Hypertension+1 more
Gilead Sciences 50
Load More Results